XML 65 R54.htm IDEA: XBRL DOCUMENT
v3.25.2

COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2025 USD ($) | Jun. 30, 2024 USD ($) | Jun. 30, 2025 USD ($) Facility Term Liters | Jun. 30, 2024 USD ($)
COMMITMENTS AND CONTINGENCIES [Abstract] |  |  |  |
Plasma supply agreement term |  |  | 10 years |
Research and development (in Dollars) | $ | $ 1,031 | $ 560 | $ 1,858 | $ 1,010
A&R Grifols Agreement [Member] |  |  |  |
COMMITMENTS AND CONTINGENCIES [Abstract] |  |  |  |
Agreement term expiring date |  |  | Sep. 30, 2039 |
Volume supplied period |  |  | 12 months |
Increase in minimum annual price, term |  |  | 12 months |
A&R Grifols Agreement [Member] |  |  |  |
COMMITMENTS AND CONTINGENCIES [Abstract] |  |  |  |
Agreement term expiring date |  |  | Jul. 31, 2031 |
Number of renewal terms (in Term) | Term |  |  | 2 |
Volume supplied period |  |  | 12 months |
Plasma purchase agreement renewal period |  |  | 5 years |
Maximum [Member] | 2011 Plasma Purchase Agreement [Member] |  |  |  |
COMMITMENTS AND CONTINGENCIES [Abstract] |  |  |  |
Number of plasma collection facilities (in Facility) | Facility |  |  | 5 |
Minimum [Member] | A&R Grifols Agreement [Member] |  |  |  |
COMMITMENTS AND CONTINGENCIES [Abstract] |  |  |  |
Quantity of RSV plasma used (in Liters) | Liters |  |  | 35,000 |
Minimum [Member] | A&R Grifols Agreement [Member] |  |  |  |
COMMITMENTS AND CONTINGENCIES [Abstract] |  |  |  |
Quantity of RSV plasma used (in Liters) | Liters |  |  | 35,000 |
ASCENIV [Member] |  |  |  |
COMMITMENTS AND CONTINGENCIES [Abstract] |  |  |  |
Research and development (in Dollars) | $ | $ 300 | $ 400 | $ 900 | $ 700

X
- Definition Date the agreement with term expired, in YYYY-MM-DD format. + References No definition available. + Details
Name: | adma_AgreementWithTermExpirationDate
Namespace Prefix: | adma_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Increase in annual price term period on usage of RSV Plasma, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | adma_IncreaseInMinimumAnnualPriceTerm
Namespace Prefix: | adma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of wholly-owned plasma collection facilities of the entity. + References No definition available. + Details
Name: | adma_NumberOfPlasmaCollectionFacilities
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of renewal terms to extend purchase agreement, if agreed to by the parties. + References No definition available. + Details
Name: | adma_NumberOfRenewalTerms
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Plasma purchase agreement renewal period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | adma_PlasmaPurchaseAgreementRenewalPeriod
Namespace Prefix: | adma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Plasma supply agreement term period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | adma_PlasmaSupplyAgreementTerm
Namespace Prefix: | adma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Respiratory Syncytial Virus (RSV) Converted human plasma used by company. + References No definition available. + Details
Name: | adma_QuantityOfRespiratorySyncytialVirusPlasmaUsed
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Supplied period on usage of RSV plasma in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | adma_RespiratorySyncytialVirusPlasmaVolumeSuppliedPeriod
Namespace Prefix: | adma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 27 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1 + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=adma_GrifolsAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=adma_KEDPlasmaAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=adma_PlasmaPurchaseAgreementOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=adma_ASCENIVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |